TRAVERE THERAPEUTICS
TRAVERE THERAPEUTICS is named as the registrant in 1 lobbying report we hold for 2026-Q2, for 1 client. 0 reports of 1 compared with the due date were posted after it.
Clients and amounts
A lobbying report states the registrant's income from the client (a lobbying firm) or its own lobbying expenses (an organization lobbying for itself), for the whole quarter and every issue together. A report of less than $5,000, or of no lobbying activity, states no figure. It is not the amount spent on one bill.
| Client | Amount the report states, by quarter | Reports |
|---|---|---|
| TRAVERE THERAPEUTICSThe registrant lobbying for itself | 2026-Q2: $140,000 in its own lobbying expenses | 1 |
Lobbyists named in these reports
- CHRISTOPHER PORTER · 1 report
- ROSE GALLAGHER · 1 report
Bills named, and how the House and the Senate voted
11 bills named in these reports. 1 of them became law, and our record holds how the House and the Senate voted on it. A lobbying report names the houses of Congress and the agencies the lobbyists contacted. It does not say which members or staff they met.
| Bill | Status | How the House and the Senate voted |
|---|---|---|
| H.R. 1An act to provide for reconciliation pursuant to title II of H. Con. Res. 14. | Became law | Public Law 119-21House 218–214 · Senate 50–50 |
| H.R. 946ORPHAN Cures Act | Introduced | No recorded vote in our record |
| H.R. 1262Mikaela Naylon Give Kids a Chance Act | Passed the House | No recorded vote in our record |
| H.R. 1414Cameron’s Law | Introduced | No recorded vote in our record |
| H.R. 1518New Era of Preventing End-Stage Kidney Disease Act | Introduced | No recorded vote in our record |
| H.R. 4709Newborn Screening Saves Lives Reauthorization Act of 2025 | Introduced | No recorded vote in our record |
| H.R. 9102BINSA Act | Introduced | No recorded vote in our record |
| S. 932Give Kids a Chance Act of 2025 | Introduced | No recorded vote in our record |
| S. 1040Drug Competition Enhancement Act | Reported by committee | No recorded vote in our record |
| S. 1862ORPHAN Cures Act | Introduced | No recorded vote in our record |
| S. 2658Medication Affordability and Patent Integrity Act | Reported by committee | No recorded vote in our record |
Issues named: Copyright/Patent/Trademark (1), Health Issues (1), Medical/Disease Research/Clinical Labs (1), Medicare/Medicaid (1), Pharmacy (1), Taxation/Internal Revenue Code (1).
Every report
| Client | Kind, as filed | Posted | Report |
|---|---|---|---|
| TRAVERE THERAPEUTICSHealth Issues, Pharmacy, Medical/Disease Research/Clinical Labs, Medicare/Medicaid, Copyright/Patent/Trademark, Taxation/Internal Revenue Code | 2nd Quarter - Report | The report on LDA.gov |
Campaign gifts this registrant reported
Lobbyists and registrants report their political contributions twice a year (form LD-203). We hold these reports only for contributions to the campaign committees of members who sponsored or cosponsored a bill named in a lobbying report. Any other contribution: Not checked yet.
No contribution report we hold lists a gift from this filer.
Where this comes from
Lobbying Disclosure Act reports (LD-2), LDA.gov. We save our own copy of each page of LDA.gov's list of reports before we read it. These pages were built from our copies on .
2026-Q2: every page of LDA.gov's list saved and read.
A lobbying report states the registrant's income from the client (a lobbying firm) or its own lobbying expenses (an organization lobbying for itself), for the whole quarter and every issue together. A report of less than $5,000, or of no lobbying activity, states no figure. It is not the amount spent on one bill.
Senate Office of Public Records cannot vouch for the data or analyses derived from these data after the data have been retrieved from LDA.gov.